Clinical Trials List
2020-05-01 - 2025-12-31
Phase II
Recruiting5
ICD-10C53.0
Malignant neoplasm of endocervix
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9180.0
Malignant neoplasm of endocervix
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 陳宇立 Division of Obstetrics & Gynecology
- - - Division of Obstetrics & Gynecology
- YING-CHENG CHIANG Division of Obstetrics & Gynecology
- 童寶玲 Division of Obstetrics & Gynecology
- 施怡倫 Division of Radiology
- 戴依柔 Division of Obstetrics & Gynecology
- 陳祈安 Division of Obstetrics & Gynecology
- BOR-CHING SHEU Division of Obstetrics & Gynecology
- CHI-HAU CHEN CHI-HAU CHEN Division of Obstetrics & Gynecology
- 郭冠廷 Division of Others
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ting-Chang Chang Division of Obstetrics & Gynecology
- 黃彥綾 Division of Radiology
- Chyong-Huey Lai Division of Obstetrics & Gynecology
- Angel Chao Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- 周宏學 Division of Obstetrics & Gynecology
- Yun-Hsin Tang Division of Obstetrics & Gynecology
- 黃寬仁 Division of Obstetrics & Gynecology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Chi-Mu Chuang Division of Obstetrics & Gynecology
- Huann-Cheng Horng Division of Obstetrics & Gynecology
- 吳華席 Division of Obstetrics & Gynecology
- Yi-Jen Chen Division of Obstetrics & Gynecology
- 沈書慧 Division of Radiology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
約30 participants
-
Global
160 participants
